Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.


Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Drug Approval Feed Articles ...

Rituximab Effective for Pemphigus. FDA to Expedite the Review Process
Bing Pharma News, raredr.com, 27-Mar-2017
Rituximab Effective for Pemphigus. FDA to Expedite the Review Process
Beyond the Cholesterol-Lowering Effect of Soy Protein: A Review of the Effects of Dietary Soy and Its Constituents on Risk Factors for Cardiovascular Disease.
Medline, Nutrients [9], 27-Mar-2017
Novel strategies in the oral delivery of antidiabetic peptide drugs- insulin, GLP 1 and its analogs.
Medline, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 27-Mar-2017
Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection.
Medline, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [90] 24-37, 27-Mar-2017
Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.
Medline, Molecular medicine (Cambridge, Mass.) [23], 27-Mar-2017
Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?
Medline, American journal of cancer research [7] 370-382, 27-Mar-2017
Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice.
Medline, Scientific reports [7] 369, 27-Mar-2017
Reversing the anticoagulation effects of dabigatran.
Medline, Hospital practice (1995) 1-10, 27-Mar-2017
Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.
Medline, Seizure [47] 81-82, 27-Mar-2017
Structural Requirements of HDAC Inhibitors: SAHA Analogues Modified at the C2 Position Display HDAC6/8 Selectivity.
Medline, ACS medicinal chemistry letters [8] 281-286, 27-Mar-2017
Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.
Medline, ACS chemical neuroscience, 27-Mar-2017
Profiling and Preparation of Metabolites from Pyragrel in Human Urine by Online Solid-Phase Extraction Coupled with High Performance Liquid Chromatography Tandem Mass Spectrometry Followed by a Macroporous Resin-Based Purification Approach.
Medline, Molecules (Basel, Switzerland) [22], 27-Mar-2017
Fluorouracil enhances photodynamic therapy of squamous cell carcinoma via a p53 -independent mechanism that increases protoporphyrin IX levels and tumor cell death.
Medline, Molecular cancer therapeutics, 27-Mar-2017
A chemical chaperone improves muscle function in mice with a RyR1 mutation.
Medline, Nature communications [8] 14659, 27-Mar-2017
Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
Medline, Expert opinion on pharmacotherapy, 27-Mar-2017
Synthesis of 3-O-sulfated oligosaccharides to understand the relationship between structures and functions of heparan sulfate.
Medline, Journal of the American Chemical Society, 27-Mar-2017
CNS Demyelination with TNF-α Blockers.
Medline, Current neurology and neuroscience reports [17] 36, 27-Mar-2017
A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfa.
Medline, Transfusion, 27-Mar-2017
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Were Treated With H.P. Acthar Gel After an Incomplete Response to Combinations of DMARDs and Biologic DMRADs
ClinicalTrials.gov, , 27-Mar-2017
Showing Records 0 ... 20  


SciBite
The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts

About/Links

Query: Drug Approval Feed
Type: Query